Rare diseases
Investigational molecules
Locations
Back to France41 clinical trials in Poissy, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceStudy comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment
FranceStudy on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis
FranceStudy on Colchicine and Aspirin for Improving Heart Health in Adults with Type 2 Diabetes Without Previous Heart Events
FranceStudy on the Use of Epinephrine for Newborns with Cardiac Arrest at Birth
FranceStudy on the Physical Impact of Multiple Sclerosis and Continued Access to Ocrelizumab for Patients Previously in a Related Study
FranceStudy on Short vs. Standard Amoxicillin Treatment for Adults with Lower Limb Erysipelas
FranceStudy on Nifedipine for Managing Preterm Premature Rupture of Membranes (PPROM) in Pregnant Women Before 34 Weeks
FranceStudy on Sedation Effects of Dexmedetomidine vs. Midazolam in Mechanically Ventilated Preterm Infants
FranceStudy on Stopping Omalizumab in Patients with Well-Controlled Severe Allergic Asthma After 3 Years of Treatment
FranceStudy of Pioglitazone and Avelumab Combined with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients with Complete Cytogenetic Response
FranceStudy on Tranexamic Acid to Prevent Blood Loss in Women with Placenta Previa Undergoing Cesarean Delivery
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Multiple Sclerosis treatments, including innovative therapies and comparative studies of various medications. Studies evaluate new treatment approaches like anti-CD20 maintenance and de-escalation strategies.
Multiple clinical trials are testing novel therapeutic agents to reduce disease activity and improve patient outcomes.
Critical research in neonatal medicine addressing various conditions affecting premature infants and newborns, including respiratory distress syndrome and hyperglycemia management.
Studies focus on improving survival rates and developing better treatment protocols for vulnerable newborns.
Innovative research examining cardiovascular health in high-risk populations, particularly focusing on prevention strategies in diabetic patients without prior cardiovascular events.
Clinical trials evaluating new treatment combinations to reduce cardiovascular events in at-risk populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
